Bedrijfsoverzicht
Alto Ingredients, Inc. is a specialty manufacturer and distributor based in the United States that focuses on the production, distribution, and marketing of specialty alcohols, renewable fuel, and essential ingredients. The company operates within the Basic Materials sector, specifically within the Specialty Chemicals industry, positioning itself as a provider of specialized chemical solutions rather than bulk commodities. This operational scope is supported by a workforce of 390 employees who manage operations across three distinct segments: Marketing and Distribution, Pekin Campus Production, and Western Production. With a market capitalization of $370.86M and annual revenues reaching $917.93M, Alto Ingredients represents a mid-cap entity that maintains a substantial revenue base relative to its employee count. The revenue figure of $917.93M suggests a diversified distribution network capable of generating significant top-line volume, while the market cap indicates that the broader market values the company's specialized niche at approximately four times its annual revenue, reflecting a valuation premium often seen in sectors with high gross margin requirements or specific regulatory moats.
Financiële gezondheid
The company reported revenue of $917.93M for the trailing twelve months, generating a net income of $12.07M and an EBITDA of $32.92M. The substantial disparity between the $917.93M in revenue and the $12.07M in net income highlights a cost structure with significant overheads, taxes, and operating expenses that consume approximately 88.5% of gross revenue before reaching the bottom line. Free cash flow stands at -$7,551,500, indicating that current capital expenditures and working capital requirements are outpacing cash generation from operations, which limits immediate financial flexibility for large-scale discretionary investments or aggressive debt repayment without external financing. The company's margins reveal a highly competitive pricing environment, with a gross margin of 3.8%, an operating margin of 3.6%, and a profit margin of 1.5%, suggesting that the business relies on volume or specific contractual advantages rather than high per-unit pricing power to maintain profitability. On the balance sheet, Alto Ingredients holds $23.41M in cash against $97.60M in debt, resulting in a debt-to-equity ratio of 39.80%, which indicates a leveraged capital structure where equity financing plays a critical role in offsetting liabilities. Despite the debt load, the current ratio of 2.64 demonstrates robust short-term liquidity, showing that current assets are more than double current liabilities, providing a comfortable buffer for meeting immediate obligations. Return on Equity is 5.7% and Return on Assets is 1.2%, metrics that reveal management effectiveness is currently modest, as the company generates relatively low returns on the capital deployed to support its asset base and equity value.
Waarderingsbeoordeling
Alto Ingredients trades with a P/E ratio of 29.97 based on trailing twelve-month earnings, while the forward P/E is significantly lower at 12.62. This wide divergence between the trailing and forward multiples implies that the market anticipates a substantial improvement in earnings trajectory over the coming year, potentially driven by cost reductions, volume growth, or margin expansion, although the specific drivers for this earnings multiple compression are not explicitly detailed in the current financial snapshot. The price-to-book ratio stands at 1.51, indicating that the market values the company at 1.51 times its book value, which suggests a moderate premium over the net asset value of the firm. Alternative valuation metrics provide further context, with a price-to-sales ratio of 0.40 and an EV/EBITDA of 13.51, suggesting the stock is priced at a discount relative to sales despite its low profitability, which is typical for capital-intensive industries with high fixed costs. Over the past year, the stock has exhibited significant price volatility, trading between a 52-week high of $5.10 and a 52-week low of $0.77. Without the current share price, the precise percentage distance from the 52-week high cannot be calculated, but the range of $4.33 demonstrates that the stock has experienced extreme swings, moving from a depressed level near its low to a high point that represents a 565% increase from the low. The beta value is 0.06, which is exceptionally low and indicates that the stock price is virtually uncorrelated with the broader market movements, behaving more like a defensive asset or a non-systematic play.
Growth & Income
Revenue growth year-over-year is -1.9%, while earnings growth is listed as N/A, meaning the company did not report a positive earnings growth rate for the period. The negative revenue growth indicates a contraction in sales volume or pricing power, and since earnings growth is unavailable, it is unclear if earnings are growing faster or slower than revenue, but the shrinking top line generally pressures the bottom line in a low-margin environment. As a non-dividend payer, the company does not distribute a dividend yield or payout ratio, as the dividend yield is N/A and the payout ratio is 0.0%. This lack of dividend distribution implies that the company retains all of its earnings to reinvest into growth initiatives, operational improvements, or to service its debt obligations rather than providing income to shareholders. The overall growth and income profile is characterized by a contraction in top-line sales and a complete absence of dividend income, positioning the stock strictly as a potential growth or turnaround play rather than an income-generating vehicle for investors seeking current yield.